Related Experiment Videos
Haematocrit and plasma viscosity in atrial fibrillation
International Journal of Cardiology
|July 27, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Molecular Pathology of Non-Malignant Haematological Disease.
British journal of biomedical science·2026
The Molecular Pathology of Blood Cancer: A Comprehensive Review of Chromosome and Genetic Abnormalities and Their Clinical Utility.
British journal of biomedical science·2026
SARS-CoV-2 and COVID-19: A Narrative Review.
British journal of biomedical science·2022
Angiogenesis, Metabolism, Endothelial and Platelet Markers in Diabetes and Cardiovascular Disease.
British journal of biomedical science·2022
Non-coding RNAs - A primer for the laboratory scientist.
British journal of biomedical science·2019
Ai-based multimodal analysis of ECG and clinical data for evaluation for competitive sports participation: The VALETUDO trial.
International journal of cardiology·2026
Erosion and embolization after transcatheter atrial septal defect closure: Findings from a multicenter international survey.
International journal of cardiology·2026
Endothelial dysfunction and long-term outcomes in patients with myocardial infarction and non-obstructive coronary arteries.
International journal of cardiology·2026
Tracking arterial stiffness from childhood to adolescence: the role of adiposity and cardiometabolic factors.
International journal of cardiology·2026
Valvular heart failure is a distinct heart transplant phenotype with comparable adjusted survival to other heart failure etiologies.
International journal of cardiology·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026